Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

JUBILANT PHARMOVA LTD.

NSE : JUBLPHARMABSE : 530019ISIN CODE : INE700A01033Industry : Pharmaceuticals & DrugsHouse : Jubilant Bhartia
BSE830.5521.65 (+2.68 %)
PREV CLOSE () 808.90
OPEN PRICE () 809.75
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 11493
TODAY'S LOW / HIGH ()788.55 834.85
52 WK LOW / HIGH ()783.75 1250
NSE827.6520 (+2.48 %)
PREV CLOSE() 807.65
OPEN PRICE () 804.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 827.65 (5)
VOLUME 247175
TODAY'S LOW / HIGH() 789.70 834.00
52 WK LOW / HIGH ()786.05 1248
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1978

Management Info :

Shyam S Bhartia - Chairman Priyavrat Bhartia - Managing Director

Registered Office :

Address : Bhartiagram ,Jyotiba Phoolay Nagar, ,
Gajraula,
Uttar Pradesh-244223

Phone : 05924-267437

Registrar's Details : Alankit Assignments Ltd.
205-208 , Anarkali Complex,Jhandewala Extension,,New Delhi
Listing : BSE, NSE
NEWS
31Dec Jubilant Pharmova’s arm makes investme
Jubilant Pharmova’s step down wholly owned subsidiary -- Jubilant Generi..
02Dec Jubilant Pharmova informs about appoi
Jubilant Pharmova has informed about the appointment of Daniel J. O’Conn..
05Nov Jubilant Pharmova’s arm gets 9 observa
U.S. Food and Drug Administration (USFDA) has concluded audit at Jubilan..
31Oct Jubilant Pharmova informs about outcom
Pursuant to the provisions of Regulation 33 read with Regulation 30 and..
10Oct Jubilant Pharmova informs about press
Pursuant to Regulation 30 of the Securities and Exchange Board of India..
Financials
in Millions
QTR Dec 25 ANNUAL 25
Net Profit66192
Gross Profit 101 376
Operating Profit 1261317
Net Sales 6737457
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
RPG Life Sciences (BSE)
 1970.30 (4.30%)
M.Cap ( in Cr)
3258.68
Ajanta Pharma (BSE)
 3122.15 (2.52%)
M.Cap ( in Cr)
39006.78
Venus Remedies (BSE)
 927.50 (7.46%)
M.Cap ( in Cr)
1239.79
Ipca Laboratories (BSE)
 1559.55 (1.79%)
M.Cap ( in Cr)
39566.44
Innova Captab (BSE)
 713.80 (2.84%)
M.Cap ( in Cr)
4084.72
Shareholding Pattern
PROMOTERS 47.68%
NON-INSTITUTION 25.14%
MUTUAL FUNDS/UTI 7.69%
FI/BANKS/INSURANCE 1.13%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX76034.42-829.29 (-1.08%)
NIFTY23639.15-227.70 (-0.95%)
Dow Jones 47417.27-289.24 (-0.61%)
Nasdaq 22716.1319.04 (0.08%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI